HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

4th Edition of International Conference on Tissue Engineering and Regenerative Medicine

September 19-21 | Rome, Italy

September 19 -21, 2024 | Rome, Italy
TERMC 2023

Georgios Koliakos

Georgios Koliakos, Speaker at Regenerative Medicine Conferences
Biohellenika Biotechnology, Greece
Title : Laminin peptides attached to hydrogels may serve as flexible scaffolds for tissue repair

Abstract:

Tissue engineering and regenerative medicine seek innovative solutions to promote effective tissue regeneration. Laminins, essential components of the extracellular matrix, possess unique cell-adhesive properties crucial for tissue development and repair. A series of laminin derived bioactive peptides has been reported, including cell adhesion promoting peptides cell differentiation and proliferation promoting peptides, angiogenesis promoting  peptides and cell migration promoting peptides. By incorporating laminin peptides into hydrogel scaffolds, our group aims to mimic the natural cellular microenvironment and enhance tissue regeneration. The combination of laminin peptides and hydrogels provides a flexible and bioactive platform that supports cell attachment, migration, and differentiation. This review explores the potential applications of laminin peptide-modified hydrogels as versatile scaffolds in tissue engineering, offering promising avenues for improved tissue repair and regeneration strategies. Furthermore, the use of laminin peptides attached to hydrogels offers several advantages in tissue repair. These peptide-modified hydrogels can be easily tailored to mimic specific tissue types by incorporating different laminin isoforms or combinations thereof. The flexibility of hydrogels allows for precise control over mechanical properties, porosity, and degradation kinetics, enabling optimal conditions for cellular growth and tissue integration. Laminin peptide-modified hydrogels can also provide a bioactive environment that facilitates cell-matrix interactions and signaling pathways crucial for tissue regeneration. The presence of laminin peptides promotes cell adhesion, proliferation, and migration, enhancing the recruitment and organization of cells at the site of injury. Additionally, these peptides can influence cell fate determination and differentiation, facilitating the regeneration of a functional tissue. The combination of laminin peptides and hydrogels holds significant potential in various fields of tissue repair, including wound healing, bone regeneration, and organ engineering. The modular nature of this approach allows for the development of customizable and patient-specific scaffolds that can be readily translated into clinical applications. In conclusion, the integration of laminin peptides into hydrogel scaffolds presents an innovative strategy for tissue repair and regeneration. This bioactive platform offers a flexible and tailored environment for cell growth and tissue integration, ultimately promoting improved outcomes in regenerative medicine. Further research and development in this field will undoubtedly contribute to advancements in tissue engineering and the eventual clinical translation of these promising technologies.

Biography:

George Koliakos was born in Thessaloniki Greece at 1956. He is a graduate of Medical School Aristotle University (MD 1979) and has a doctoral degree in Biochemistry from the same school (PhD 1983). He specialized in Nuclear Medicine (1983-1987) He served as a postdoctoral associate at the medical school of the university of Minessota USA (1987-1989) and was a visiting research professor at the university of Miami USA (1993). Since 1989 he is a faculty member of the Medical School   Aristotle University serving since 2012 as a  professor of Biochemistry. He is since 2019 the director of the Joint postgraduate program of Aristotle University Thessaloniki and Democritus University Thrace “Stem Cell and Regenerative medicine”, editor of the “Aristotle Biomedical Journal”  and president of the “Hellenic Society for Regenerative Medicine Research”. He served as Director of the Laboratory of Clinical Biochemistry AHEPA University Hospital (2016-2019), Director of the Laboratory of Biological Chemistry Medical School Aristotle University (2018-2020) Head of the Department of Biological Sciences and Preventive Medicine (2017-2019 and 2020-2021). He also has served as member of the board of the Hellenic Society of Biochemistry and Molecular Biology, Member of the board of the Hellenic Society of Nuclear Medicine and coeditor of Hellenic Journal of Nuclear Medicine. Cofounder and associate manager of Hippocrates Diagnostic Center in Thessaloniki (1991-2006). CEO, of the Hellenic National Research Center Stem cell Bank (2007-1014).  Currently, founder President  and CEO of Biohellenika biotechnology company (since 2006). George Koliakos has co authored 191 peer reviewed papers listed in Pubmed and Scopus with more than 5300 citations and a current Hills Index of 38 (Google Scholar).  He was a principal investigator in 17 national research Grants and inventor or coinventor in eight patents.

 

Watsapp